MFS
PCVX icon

Mirabella Financial Services’s Vaxcyte PCVX Stock Holding History

Mirabella Financial Services’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-9,432
Closed -$466K – 441
2020
Q3 		$466K Buy
+9,432
New +$376K 0.06% 149

Other funds holding PCVX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Mirabella Financial Services's PCVX Position: Q4 2020 in Review

Mirabella Financial Services sold out of Vaxcyte (PCVX) in Q4 2020, closing a stake of 9,432 shares — an estimated $466K sold.

Mirabella Financial Services first reported a position in PCVX in Q3 2020 and held it in 1 quarter. The position peaked at $466K in Q3 2020. 83 funds tracked by Wall St. Rank hold PCVX as of Q4 2020.

  • Mirabella Financial Services reported no remaining Vaxcyte position as of Q4 2020 after selling out during the quarter.
  • Mirabella Financial Services sold 9,432 Vaxcyte shares in Q4 2020, an estimated $466K.
  • Mirabella Financial Services first reported a position in Vaxcyte in Q3 2020 and held it in 1 quarter.
  • Mirabella Financial Services's Vaxcyte position peaked at $466K in Q3 2020.
  • 83 funds tracked by Wall St. Rank held Vaxcyte as of Q4 2020.

Based on Mirabella Financial Services's 13F filing for Q4 2020, filed 16 Feb 2021.